Cenforce — Research Summary
Cenforce 150 mg is a sildenafil citrate formulation developed by Centurion Laboratories for laboratory investigation of phosphodiesterase type 5 (PDE5) enzyme inhibition pathways. This compound serves as a reference standard for researchers at Stroid UK Shop examining cardiovascular and smooth muscle cellular mechanisms. Sildenafil citrate belongs to the class of selective PDE5 inhibitors, originally developed for pulmonary hypertension research before expanding into broader vascular studies. Laboratory investigations focus on its ability to modulate cyclic guanosine monophosphate (cGMP) degradation pathways in various tissue models.
Laboratory Research Applications
Research applications for Cenforce 150 mg centre on examining PDE5 enzyme kinetics and cellular signalling cascades. Scientists investigate its effects on nitric oxide-mediated vasodilation in isolated vascular preparations and endothelial cell cultures. Comparative studies with other PDE inhibitor compounds available in our Cenforce research category allow for comprehensive enzyme selectivity analysis. Research protocols examine concentration-dependent responses in smooth muscle contraction assays and calcium channel modulation studies. Additional investigations explore interactions with selective androgen receptor modulators and bioactive peptides in combined research models to understand multi-pathway cardiovascular mechanisms.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Sildenafil Citrate |
| Strength | 150 mg |
| Manufacturer | Centurion Laboratories |
| CAS Number | 139755-83-2 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
| Solubility | Water soluble as citrate salt |
Research Compliance
This product is manufactured exclusively for in-vitro research purposes and laboratory analysis. Cenforce 150 mg is not approved for human consumption, therapeutic use, or any clinical application. Researchers must ensure proper laboratory protocols, safety equipment, and waste disposal procedures when handling this compound. All studies should be conducted under appropriate institutional oversight with proper documentation of research objectives and methodologies.
